Posted by Michael Wonder on 23 May 2023
FDA approves prescription nasal spray to reverse opioid overdose
22 May 2023 - Nalmefene hydrochloride product in nasal spray form provides additional tool for harm reduction groups and first responders.
Today, the US FDA approved Opvee, the first nalmefene hydrochloride nasal spray for the emergency treatment of known or suspected opioid overdose in adults and paediatric patients 12 years of age and older. This is the first FDA approval of nalmefene hydrochloride nasal spray for health care and community use.
